It’s Back to the Future, telemedicine style. The doctor with his black bag of remedies and devices knocking at your door for a house call is an old idea. But a tricked-out, high-tech ride brings a fresh, 21st century twist to that form of healthcare. Add the brains of University of Kansas students to resources […]
The Verizon Foundation donated $30,000 to Via Christi Health Tuesday morning to support the health system's ePharmacy program, according to a Via Christi news release. The program uses software to connect health care providers, and it provides electron...
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
UPDATED 1/7/13 After withdrawing an initial public offering early last summer, a company employing a two-pronged approach to immunotherapy is raising private capital as it looks toward phase 3 trials of brain and kidney cancer drugs. A December U.S. Securities and Exchange Commission filing indicates that TVAX Biomedical Inc. had raised $2 million in private […]
When endotracheal intubations are performed on critically ill patients in the intensive care unit or by emergency medical respondents,there is a risk that the cuff is improperly inflated. Both overinflation and underinflation of the cuff results in extended hospital stay for patients and is thus expensive. But underinflation is more problematic in that it increases […]
Clinical research organization Clinipace Worldwide has acquired Colorado firm Regulus Pharmaceutical Consulting in a move to bolster its regulatory offerings to pharmaceutical companies.
Credit for this blog post should really go to William Hoffman, an editor and writer with the University of Minnesota medical school and author of “The Stem Cell Dilemma.” Hoffman e-mailed me after reading my post on how the Democratic candidates for governor rank on biosciences. He specifically focused on the idea that Minnesota’s high […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Kansas Venture Capital Inc. hopes to triple sales at the acquired company, to be called KCAS LLC, within five years.